Cancer cells often exploit the UPS to promote survival and proliferation. Mutations or dysregulations in components of the UPS can lead to the accumulation of oncogenic proteins or the degradation of tumor suppressors. For example, the E3 ligase MDM2 targets the tumor suppressor protein p53 for degradation, and overexpression of MDM2 is observed in various cancers, contributing to tumor growth and chemoresistance.
